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IN a previous study (Chang & Turk,
1977) we found that prior splenectomy
protected BALB/c mice against a
syngeneic methylcholanthrene-induced
tumour (Meth A; Old et al., 1962) inocu-
lated i.p. This protection occurred only
when the mice were given 103-104 cells
(not outside this dose range). Subsequently
we discovered that at least some of the
mice and the tumour had become infected
with lactic dehydrogenase-elevating virus
(Riley virus; LDV) which is a common
passenger of many murine tumours (Riley
et al., 1960; Notkins, 1965).
Infected mice have a life-long viraemia
and a raised level of lactic dehydrogenase
(LDH) in the serum (Riley et al., 1960).
Infection with LDV has been shown to
prolong the retention of allogeneic skin
grafts (Howard et al., 1969), to potentiate
the growth of some tumours (Riley &
Spackman, 1976), to exacerbate malarial
infections (Plasmodium yoelii; Henderson
et al., 1978) and to increase or decrease
antibody responses, depending upon the
relative times of inoculation of virus and
antigen injection (Notkins et al., 1966;
Michaelides & Simms, 1977).
In this paper, we present the results of
various experiments to determine the
influence of LDV infection on the resis-
tance of splenectomized and intact mice
to i.p. inoculation ofMeth A tumour cells.
Inbred BALB/c mice which had been
screened for LDV infection were used.
The level ofLDH in the serum was used to
Accepted 21 December 1978
indicate the presence of the virus (Table
I). Mice were splenectomized, as pre-
viously described (Chang & Turk, 1977)
14 days before tumour-cell inoculation.
The tumour-cell line used was the ascitic
form of a 3-methyleholanthrene-induced
fibrosarcoma (Meth A) which was origin-
ally produced by Old et al. (1962) in
BALB/c mice. It is maintained in our
laboratory by serial passage in BALB/c
mice (Chang & Turk, 1977) and recently
it was found to be carrying LDV. The
tumour was freed from virus by growth
for 10 days in the brains of neonatal rats
(Table I). Unless otherwise stated, the
Meth A used was free from LDV con-
tamination.
The LDV was prepared and stored as
described by Mahy et al. (1965). The stock
virus preparation was injected i.p. into
2 mice and 3 days later, heparinized
TABLE I.- LDH levels in the serum of mice
receiving Meth A cells grown in neonatal
rat brains
No. of days culture
AMeth A in rat brains
6
6
6
7
7
10
10
Knowni LDV iinfected
Control
* Wroblewski tunits
Due, 1955).
Serum LDH levels*
in recipient mice
3870
3100
3100
3100
3870
601
553
5161
516
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plasma from these mice was diluted 1 in
10 and used to infect experimental mice
(0.1 ml i.p. per mouse; infectivity titre
of 107 LD50/ml). LDH levels were esti-
mated by measuring the rate ofconversion
of pyruvate to lactate (Reeves & Fimog-
nari, 1963). The LDH levels in virus-
infected mice were 6 to 10 times greater
than those in normal mice (Table I).
The survival of splenectomized mice
given 103 Meth A tumour cells i.p. was
compared with that of normal mice (Fig.
1). In contrast to our previous findings,
on this occasion when both mice and
tumour cells were free from LDV infec-
tion, there was no significant difference
in number of survivors between the splen-
ectomized and normal groups of mice, nor
in the mean time to death (MTD; 17-8+
1-8 days vs 21 0A3-4 days, respectively).
Similar results (not shown) were obtained
with various doses ofMeth A from 102_106
cells given i.p.
Since it was known that some of the
mice from the colony used in our previous
workwere infected with LDV, experiments
were carried out to determine what effect
an LDV infection given either one week
before or one week after splenectomy
would have on the survival of mice
inoculated i.p. with 103 Meth A cells.
In addition, since the tumour was found
to be carrying this virus, additional groups
of similarly treated mice were challenged
i.p. withtheinfectedMethA/Riley tumour
suspension (103 cells/mouse).
The results are shown in Table II.
There was no statistically significant
difference between the numbers of sur-
vivors in each group at 40 days, when the
experiment was terminated. However,
when the MTDs of each group were com-
pared there was a significant difference
between the groups of mice infected with
LDV before or after splenectomy and the
uninfected intact mice. There was no
difference in results between the groups
infected one week before and the group
infected one week after splenectomy.
There was no difference in MTD between
splenectomized and intact mice not in-
fected with LDV, as fousnd above. Similar
results were obtained with the original
Meth A/Riley tumour-cell suspension.
There is no way of knowing at what
stage the mice in our previous study were
infected with LDV. However, the greatest
risk of infection would be at or shortly
after splenectomy, or at the time of
inoculation of the tumour. Therefore, the
survival ofintact and splenectomized mice
which were either chronically or acutely
(i.e. one day after splenectomy or at the
time of inoculation with Meth A, respec-
tively) infected with LDVwas investigated
(Fig. 2). There was a significant difference
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FIG. 1.-Survival ofnormal (intact ) and splenectomized (SX ----- ) mice after 103 Meth A cells i.p.
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FIG. 2. Effect of LDV infection andt splen-
ectomy (SX) on survival of mice after i.p.
challenge with Meth A cells. Mice were
either chronically infected by injecting
LDV one (lay after splenectomy or acutely
infected by injecting the virus at the same
time as Meth A. (Intact ; SX ----- )
(Fourfold Table test, P<0 002) in survival
(and MTD) between the chronically LDV
infected splenectomized mice and the
uninfected intact and splenectomizedmice.
There was no difference in survival
between the virus-free splenectomized
mice, the chronically LDV-infected intact
mice or the acutely infected intact or
splenectomized mice, and the controls.
However, both the chronically LDV-
infected intact mice and the acutely
infected splenectomized mice had sig-
nificantly greater MTD than the controls
(Student's t Test, P<0 005).
Thus, splenectomy alone had no protec-
tive effect on the growth of LDV-free
Meth A tumour cells in virus-free mice at
any cell dose, nor did splenectomy alter
the growth of virus-infected tumour cells
in such mice. However, in mice infected
with LDV a protective effect of splen-
ectomy was seen, indicated both by an
increase in survival time and an overall
increase in the number of mice surviving
a dose of 103 tumour cells. Although we
have not been able to repeat the previous
marked effect of splenectomy, we have
shown that the mice have a better prog-
nosis when LDV infection occurs shortly
(within 24 h) after splenectomy.
It appears, therefore, that a complex
interaction between the effects of splen-
TABLE II. Effect of LDV infection one week before or after splenectomy on the survival
of normal and splenectomized BALB/c micefollowing i.p. inoculation of Meth A cells
Treatment on Day_~~~~~--
-Th
-7 0
Meth A
Meth A
Meth A
Meth A
LDV Meth A
Mleth A/
Riley
Meth A/
Riley
Meth A/
Riley
Meth A/
Riley
LDV" Meth A/
Riley
Survivors
on Day 40
2/10
0/10
2/10
5/10
6/10
2/10
MTD Student's
±s.d. ((lays) t test*
18-7±1-0
22-4±4-4 NSt
26-2 +5-6 NS
30 2±3-6 P<0-001
33.8±6.7 P<0-001
21-7 ±9-9
0/10 24-2+3-9 NS
1/10 23-8 ±5-2
6/10 26-6 ±2-0
NS
NS
5/10 314± 1 9 P=0-02
* MITD of treated groups vs uintreated in each section.
t SX=spleniectomy.
I NS=Not significant.
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ectomy and LDV infection altered the
resistance of mice to Meth A cells in the
previous experiments. The mechanism
involved has not been investigated. How-
ever, these findings further emphasize the
need to screen for the presence of this
ubiquitous virus, especially in experimen-
tal systems in which tumour lines are
maintained by passage in mice and where
there is a high risk of cross-infection; for
instance, after surgical manipulation.
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